02ProductsTwo finished-dose drug products
Capsule-form. Pharmaceutical-grade. In market.
Oral capsule preparations manufactured under Health Canada GMP, labeled in compliance with DEL requirements, and exported under international narcotic permit.
NATURAL
Natural Psilocybin Extract
4-Phosphoryloxy-N,N-dimethyltryptamine
20 Capsules
SYNTHETIC
MDMA Capsules
3,4-Methylenedioxymethamphetamine HCl
50 / 30 Capsules
Product images are for illustrative purposes only and do not reflect final commercial packaging, labeling, or presentation.
New initiative — April 2026
Ibogaine Initiative
GMP supply of ibogaine under Optimi's Health Canada-licensed manufacturing platform, launched alongside the April 2026 U.S. Executive Order on psychedelic drug products and FDA IND clearance.